| Identification | Back Directory | [Name]
BOC-D-LYS-OH | [CAS]
106719-44-2 | [Synonyms]
BOC-D-LYSINE
BOC-D-LYS-OH
N2-Boc-D-lysine
Nα-Boc-D-lysine
N-α-Boc-D-lysine
N^a-Boc-D-lysine, 98%
BOC-D-LYS-OH USP/EP/BP
N-.ALPHA.-BOC-D-LYSINE
BOC-D-Lysine(Boc-D-Lys-OH)
-allyloxycarbonyl-L-ornitine
(Tert-Butoxy)Carbonyl D-Lys-OH
N-tert-Butoxycarbonyl-D-lysine
Nalpha-Boc-D-lysine
Boc-D-Lys-OH
N-ALPHA-T-BUTOXYCARBONYL-D-LYSINE
N-ALPHA-T-BUTYLOXYCARBONYL-D-LYSINE
NALPHA-tert-Butoxycarbonyl-D-lysine
Nα-(tert-Butoxycarbonyl)-D-lysine >
N-ALPHA-TERT-BUTYLOXYCARBONYL-D-LYSINE
N2-[(1,1-Dimethylethoxy)carbonyl]-D-lysine
D-Lysine, N2-[(1,1-dimethylethoxy)carbonyl]-
-allyloxycarbonyl-L-lysine dicyclohexylammonium salt
(R)-6-Amino-2-(tert-butoxycarbonylamino)hexanoic acid
-allyloxycarbonyl-D-lysine acid dicyclohexylammonium salt
(2R)-6-amino-2-{[(tert-butoxy)carbonyl]amino}hexanoic acid
(2R)-6-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoicaci
N-alpha-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-N&epsilon
(2R)-6-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid
(2R)-6-ammonio-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]hexanoate
Boc-D-Lys(Boc)-OHQ: What is
Boc-D-Lys(Boc)-OH Q: What is the CAS Number of
Boc-D-Lys(Boc)-OH | [Molecular Formula]
C11H22N2O4 | [MDL Number]
MFCD00076956 | [MOL File]
106719-44-2.mol | [Molecular Weight]
246.3 |
| Chemical Properties | Back Directory | [Melting point ]
198 °C | [Boiling point ]
410.5±40.0 °C(Predicted) | [density ]
1.113±0.06 g/cm3(Predicted) | [refractive index ]
-22 ° (C=2, MeOH) | [storage temp. ]
2-8°C | [pka]
3.92±0.21(Predicted) | [optical activity]
[α]22/D -24°, c = 0.5% in methanol |
| Hazard Information | Back Directory | [Chemical Properties]
White powder | [Uses]
Nα-Boc-D-lysine is an N-Boc-protected form of D-Lysine (L468930). D-Lysine is the unnatural isomer of L-Lysine (L468895) that has the ability to reduce non-enzymatic glycation in vitro. D-Lysine also exists as polypeptide chains of poly-D-lysine, a nonspecific adhesion-promoting molecule that has the potential to be a polymeric drug carrier. |
|
|